TransMedics Group, Inc. (NASDAQ:TMDX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT
Company Participants
Waleed Hassanein – Founder, President, CEO & Director
Gerardo Hernandez – CFO & Treasurer
Conference Call Participants
Patrick Wood – Morgan Stanley, Research Division
Presentation
Patrick Wood
MD of Equity Research
Hi, everybody. Welcome and thanks for joining. Welcome to the — I guess, the first day of the Morgan Stanley Global Healthcare Conference. So very excitedly, for important disclosures, morganstanley.com/researchdisclosures. So yes, that’s very exciting. And very excited today to have TransMedics, we’ve got Waleed, who’s the Founder and CEO; and Gerardo, who’s the CFO here. And so I really appreciate the time. Thanks for coming guys.
Waleed Hassanein
Founder, President, CEO & Director
Thank you, Patrick.
Gerardo Hernandez
CFO & Treasurer
Thank you.
Patrick Wood
MD of Equity Research
We were just saying how thematically appropriate having Staying Alive on the soundtrack was for an organ transplant company. So it kind of works well.
Question-and-Answer Session
Patrick Wood
Morgan Stanley, Research Division
I guess — so maybe starting kind of big picture. It’s been a strong year. There’s a lot on the pipeline. Sitting here today and you had that original target of 10,000 organs. And how are you feeling about 1,000-foot view, the world and where the business is today, just big picture?
Waleed Hassanein
Founder, President, CEO & Director
We feel great. We — as Gerardo said, a few weeks back, we are already past the 10,000 target internally. We’re already setting our eyes at 20,000, 30,000 transplants by 2030. Yes, we feel great, and we’re looking forward to just continuing to execute.
Patrick Wood
Morgan Stanley, Research Division
If you think of the journey that you guys have been on getting to where you are now, is anything that sort
Read the full article here
